Autoimmune retinopathy: A Review.

Area of Science:

• Ophthalmology
• Immunology
• Oncology

Background:

• Autoimmune retinopathy (AIR) is a rare immune-mediated condition.
• It involves autoantibodies attacking the retina, potentially linked to other autoimmune diseases or cancers.
• AIR can be paraneoplastic (associated with cancer) or non-paraneoplastic.

Purpose of the Study:

• To summarize the understanding of autoimmune retinopathy.
• To highlight diagnostic challenges and current management strategies.
• To emphasize the need for further research into AIR.

Main Methods:

• Review of clinical presentation, diagnostic tools, and management of AIR.
• Discussion of subtypes like melanoma-associated retinopathy (MAR) and cancer-associated retinopathy (CAR).
• Emphasis on clinical investigation, laboratory tests (autoantibodies), and ophthalmologic examinations (ERG, OCT, visual field).

Main Results:

• AIR presents with progressive vision loss, scotomas, and photopsias, often in older adults.
• Initial fundus exams may be normal; later stages show retinal changes and possible optic disc pallor.
• Diagnosis requires a comprehensive approach including clinical evaluation, imaging, and serological tests for autoantibodies.

Conclusions:

• Effective management relies on prolonged immunosuppression and potentially antioxidant vitamins.
• The prognosis for AIR remains uncertain, underscoring the need for improved diagnostic and therapeutic strategies.
• Further research is crucial to better understand AIR and develop treatments to preserve or restore vision.